Eli Lilly’s GLP-1 pill allowed obese patients to lose up to 11.2% of their body weight after 72 weeks of treatment, the company said Thursday. This is lower than the benchmark of about 15% that analysts had been expecting — and it is also lower than the weight loss seen with a rival pill from Novo Nordisk... |